12/05/2011 - 9:42am

Following the settlement of a patent-litigation suit with Swiss drug maker Novartis over the patch Vivelle-Dot (estradiol transdermal system), a drug for treating symptoms of menopause, Mylan said it had received a patent license to begin selling its version of the drug in December 2013.

12/05/2011 - 9:41am

Senior Walmart executives regularly invoke the name of Sam Walton when it serves to reinforce a point regarding the company’s business model or the cultural principles on which Walton is said to have founded the company.

12/02/2011 - 1:43pm

A drug for treating immune system disorders is available again following a voluntary market withdrawal last summer.

12/02/2011 - 11:25am

Pfizer completed its acquisition of a drug maker that focuses on the development of skin scarring treatments.

12/01/2011 - 3:20pm

Many people with Type 2 diabetes have managed to integrate the treatments they must take into their daily lives, but many do not reach their blood-glucose goals after they start insulin therapy.

12/01/2011 - 2:24pm

Pfizer's efforts to protect the sales of its blockbuster cholesterol drug Lipitor have attracted scrutiny from members of Congress, according to published reports.

11/30/2011 - 3:55pm

While sales figures for pharmaceuticals are frequently reported on, drugs for people's four-legged friends also are a money maker.

11/30/2011 - 11:15am

Ranbaxy Labs was supposed to launch its generic version of the world's top-selling drug Wednesday, but a competitor beat it to the punch as the former waits for final Food and Drug Administration clearance.

11/29/2011 - 10:58am

A drug designed to prevent stroke and systemic embolism in patients with atrial fibrillation has been accepted for review by the Food and Drug Administration.